MPS (RaDiCo Cohort) (RaDiCo-MPS)
NCT06036693 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-02-11
Summary
The goal of this observational study is to characterize the epidemiology and natural history of MPS diseases by building a retrospective and prospective collection of extensive phenotypic data from French MPS patients.
Conditions
- Mucopolysaccharidosis I
- Mucopolysaccharidosis II
- Mucopolysaccharidosis III
- Mucopolysaccharidosis IV
- Mucopolysaccharidosis VI
- Mucopolysaccharidosis VII
- Mucopolysaccharidosis IX
- Multiple Sulfatase Deficiency Disease
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
lead OTHER_GOV
Principal Investigators
-
Thierry BILLETTE DE VILLEMEUR · INSERM UMR 1141
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-20
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- France
Study Locations
More Related Trials
-
Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics
NCT01675674 ·Status: TERMINATED
-
Natural History Study of Patients With MPS IIIA
NCT02746341 ·Status: COMPLETED
-
Natural History Study to Characterise the Course of Disease Progression in Participants With Mucopolysaccharidosis Type IIIB
NCT02293408 ·Status: TERMINATED
-
Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)
NCT02324049 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)
NCT05705674 ·Status: RECRUITING
-
Longitudinal Study of Bone Disease in Children with Mucopolysaccharidoses (MPS) I, II, and VI
NCT01521429 ·Status: COMPLETED
-
Gene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type IIIA
NCT04201405 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)
NCT00214773 ·Status: COMPLETED
-
Natural History Study of Patients With Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)
NCT01509768 ·Status: COMPLETED
-
A Study in MPS VI to Assess Safety and Efficacy of Odiparcil
NCT03370653 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIA
NCT04360265 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Efficacy of Heat-shock Protein (HSP) Inhibitors in Myeloproliferative Syndromes (MPS)
NCT02873832 ·Status: COMPLETED
-
A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
NCT02493998 ·Status: COMPLETED
-
A Retrospective Chart Review of Deceased Patients With Mucopolysaccharidosis Type IIIB
NCT02293382 ·Status: COMPLETED
-
Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children
NCT01938014 ·Status: COMPLETED
-
A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome
NCT02126995 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)
NCT02230566 ·Status: COMPLETED ·Phase: PHASE3
-
A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
NCT02618512 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
NCT01707433 ·Status: COMPLETED
-
Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy
NCT05665036 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I
NCT00912925 ·Status: COMPLETED ·Phase: PHASE3
-
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
NCT06078553 ·Status: RECRUITING
-
Registry of Patients Diagnosed With Lysosomal Storage Diseases
NCT05619900 ·Status: RECRUITING
-
Gene Therapy With Modified Autologous Hematopoietic Stem Cells for the Treatment of Patients With Mucopolysaccharidosis Type I, Hurler Variant
NCT03488394 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression
NCT06079567 ·Status: RECRUITING ·Phase: NA